IMAC Holdings (BACK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BACK IMAC Holdings

Watchlist

1.0800
-0.0400-3.57%

Close Nov 22 16:00 ET

1.0000
-0.0800-7.41%

Post 17:15 ET

2.04MMarket Cap-197P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

IMAC Holdings, Inc. Receives Nasdaq Deficiency Notification for Late 10-Q Filing
Quiver QuantitativeNov 22 17:20 ET
Express News | iMac Holdings Inc - Enters Agreement to Issue 4,676 Shares of Series G Preferred Stock
ReutersNov 22 17:16 ET
IMAC Holdings Granted Extension by Nasdaq to Regain Compliance With Listing Rule 5250(c)(1)
GlobeNewswireNov 14 09:10 ET
Express News | iMac Holdings Granted Extension by Nasdaq to Regain Compliance With Listing Rule 5250(C)(1)
ReutersNov 14 09:03 ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
BenzingaOct 17 08:10 ET
IMAC Holdings Welcomes Jeffrey Busch to Strengthen Board
TipRanksSep 25 16:29 ET

Comments

Stock_Drift

23 hours ago

Nasdaq keeps dropping hits this fine Friday. 🙃

$IMAC Holdings (BACK.US)$

Jaguar8

23 hours ago

NEWS

$IMAC Holdings (BACK.US)$
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
IMAC Holdings (NASDAQ: BACK) has received a deficiency notification from Nasdaq due to its failure to timely file its Q3 2024 Form 10-Q. The company now has until January 21, 2024, to submit a compliance plan. If Nasdaq accepts the plan, IMAC may receive up to 180 calendar days (until May 19, 2025) to regain compliance. While the notice has no imme...

Jaguar8

Nov 14 08:17

NEWS

$IMAC Holdings (BACK.US)$
IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)

Jaguar8

Sep 19 09:01

NEWS

$IMAC Holdings (BACK.US)$
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
IMAC Holdings Inc. (Nasdaq: BACK) has launched a new subsidiary, Ignite Proteomics , introducing a groundbreaking precision oncology assay for breast cancer treatment using Reverse Phase Protein Array (RPPA) technology. This follows IMAC's acquisition of key assets from Theralink Technologies, Inc. A landmark clinical case stud...